TIMOTHY J. CORRIGAN, District Judge.
Still pending before the Court is Plaintiff's Motion to Set Aside the Judgment Pursuant to Federal Rule of Civil Procedure 60(b)(2) and 60(b)(3). (Doc. 345). The Court previously informed the parties that it intended to deny that motion, but ordered Defendant Johnson & Johnson Vision Care, Inc. to show cause why it should not have to pay reasonable attorneys' fees and costs associated with Plaintiff Rembrandt Vision Technologies L.P.'s post-trial investigation of Dr. Bielawski. (Doc. 393).
JJVC responded to the Order, (Doc. 397), and Rembrandt filed a reply, (Doc. 400). Rembrandt also filed a motion asking the Court to reopen discovery to investigate whether JJVC and its counsel knew about Dr. Bielawski's false testimony, (Doc. 396), which JJVC opposed, (Doc. 399). JJVC has also informed the Court that Rembrandt has filed an open records request with the University of Texas to obtain some of the same information it seeks through the reopening of discovery, and JJVC asks protection from that records request. (Doc. 401).
In determining in its previous Order to deny Rembrandt's Rule 60 motion, the Court stated:
(Doc. 393 at 11). The Court thus directed JJVC "to show cause why it should not have to pay reasonable attorneys' fees and costs associated with Rembrandt's post-trial investigation of Dr. Bielawski and the motion practice occasioned thereby." (Doc. 393 at 12).
Because JJVC was the prevailing party on the Rule 60 motion, the Court questioned whether it had the authority to award fees against JJVC. As such, rather than determining to award such fees
The Court must now determine the amount of those fees and costs. That Rembrandt says it has incurred almost $1 million ($939,159.55) in attorneys' fees and costs just in investigating and litigating this one post-trial issue is difficult to fathom. While the Court might normally feel compelled to ask for more justification for this amount, JJVC does not seriously challenge it. Rather, JJVC says the Court's award should focus on the investigation which led to the discovery of Dr. Bielawski's false testimony and not to the ultimately unsuccessful efforts to reopen discovery or for Rule 60 relief.
The Court, in its discretion, decides that it will award Rembrandt the $313,219.82 the parties agree was incurred in investigating and proving Dr. Bielawski's misconduct. The Court also will exercise its discretion to vacate the cost judgment of $188,572.89 entered in favor of JJVC as the prevailing party in the underlying litigation (which amount has not yet been paid by Rembrandt).
Having made this decision, the Court will deny Rembrandt's renewed motion to reopen discovery and deny JJVC's request to get involved in the Texas litigation. Until and unless further instructed by the Federal Circuit, this is the last Order this Court intends to enter in this case.
Accordingly, it is hereby
1. Incorporating the Court's previous Order, 2014 WL 3385039 (M.D. Fla. July 10, 2014) (Doc. 393), Plaintiff's Motion to Set Aside the Judgment Pursuant to Federal Rule of Civil Procedure 60(b)(2) and 60(b)(3) (Doc. 345) is
2. The Order to Show Cause (Doc. 393) is
3. No later than
3. The Court's Order on costs (Doc. 333) is amended insofar as the award of costs is
4. Plaintiff's Second and Renewed Motion to Reopen and Compel Discovery (Doc. 396) is
5. To the extent that JJVC's notice regarding the Texas litigation (Doc. 401) seeks affirmative relief, that request is
6. The Clerk should close the file.